Archive | Democratic Republic of Congo

RSS feed for this section

Strengthening Governance in Pharmaceutical Systems: A Compendium of Country Case Studies

SIAPS and its predecessor programs have assisted numerous countries in strengthening governance to promote robust decision making, enhance accountability, reduce opportunities for corruption, and improve efficiencies to enable better access to and use of quality-assured medicines. This compendium draws on these experiences and provides a collection of examples of strategies and approaches for strengthening governance in pharmaceutical systems. The compendium highlights accumulated insights into factors that may have enabled or constrained the success of governance improvement initiatives. The intention is to systematically bolster knowledge, in alignment with USAID’s collaborating, learning, and adapting approach, so that stakeholders may examine the applicability of lessons learned and apply them in different settings to maximize resources and attain better development results. The compendium begins by defining governance, then explains its importance in pharmaceutical systems and introduces the framework SIAPS has used to guide its governance strengthening activities. It presents eight case studies on SIAPS’ work in enhancing governance in pharmaceutical systems, summarizes challenges commonly encountered and lessons learned, and closes with some reflections on the usefulness of SIAPS’ governance-strengthening framework.

Read full story · Comments are closed

SIAPS Democratic Republic of the Congo End of Project Report

Project dates: October 2011–December 2016

Read full story · Comments are closed

In the news: Defeating Malaria through Pharmaceutical Systems Strengthening

SIAPS’ role to control malaria was recently featured in Health & Humanitarian: The Supply Chain Review. Between 2000 and 2015, malaria case incidences declined by 41% and mortality rates by 62%. However, approximately 212 million people were infected and 429,000 people died in 2015, with the majority being children under the age of 5 in […]

Read full story · Comments { 0 }

Defeating malaria through pharmaceutical systems strengthening

SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.

Read full story · Comments are closed

Defeating malaria through pharmaceutical systems strengthening: A review of SIAPS’s activities in eight countries

SIAPS recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria. This report summarizes systems strengthening interventions that support the prevention and treatment of malaria. With funding from the US President’s Malaria Initiative (PMI) and based […]

Read full story · Comments { 0 }

Implementing QuanTB to Improve Forecasting, Supply Planning, and Early Warning Systems for TB Medicines: Democratic Republic of the Congo Report

The goal of this project was to conduct a review of SIAPS TB technical assistance and QuanTB implementation in DRC. Specific objectives were to determine:

  • Key achievements or results of SIAPS QuanTB technical assistance in DRC
  • Experiences and perspectives of the beneficiaries from the NTP
  • Challenges and lessons learned

This report summarizes key aspects and results of the review.

Read full story · Comments are closed

Technical Highlight: Strengthening Regulatory Systems in Democratic Republic of the Congo to Improve Access to Safe, Effective, and Quality Medicines

Chronic underfunding of the health sector coupled with long-term civil unrest in the Democratic Republic of the Congo (DRC) has contributed to insufficient regulatory capacity to effectively manage the registration and approval of new medicines in the country. In partnership with the USAID-funded SIAPS Program, the country’s Ministry of Health supported a number of broad interventions to strengthen DRC’s pharmaceutical regulatory system. SIAPS provides technical assistance to the three national control programs—malaria, HIV/AIDS, and tuberculosis—to improving access to quality medicines and other commodities and increase the potential for achieving desired health outcomes.

Read full story · Comments are closed

Addressing the Challenge of Supply Coordination in DRC: SIAPS and the National Malaria Control Program in Haut-Katanga

By Dr. Jonathan Luc Matala, Moise Kazadi, and Pacifique Bwenge Supply chain management includes coordinating and collaborating with partners at all levels, who serve as links to the end users, to ensure that commodities are available when and where they are needed, thereby avoiding wastage and expiry. To strengthen DRC’s interventions and coordinate its supporting […]

Read full story · Comments { 0 }

DRC Launching Pilot Standard Therapeutic Guidelines for Hospitals and Improving Patient Care with Drug Therapeutic Committees

By Dr. Jonathan Luc Matala and Julie Mbo In 2012, DRC decided to reinforce drug therapeutic committees (DTCs) in nine hospitals that were previously installed by the Strengthening Pharmaceutical Systems (SPS) Program. DRC asked the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, which is funded by the US Agency for International Development […]

Read full story · Comments { 0 }

Strengthening Regulatory Systems to Improve Access to Safe, Effective, and Quality Medicines

SIAPS technical support has helped strengthen the capacity of the national registration committee and streamline medicines registration. As a result, the number of registered medicines has increased from 200 in 2010 to over 3,000 in 2014; 72% of the medicines included on DRC’s essential medicines list currently have at least one product registered, up from 44% in 2011. The backlog of applications has been completely eliminated and the time taken to process a new application has been reduced from a peak of 85 days in 2013 to 64 days at the end of 2014.

Read full story · Comments are closed